Dosage unit comprising a prostaglandin analog for treating constipation
AssigneeSucampo AG
InventorsRyuji Ueno, Myra L. Patchen
Life of this patent
Estimating the term…
Abstract
A dosage unit for treating constipation in a human patient is described. The dosage unit of the invention comprises a halogenated prostaglandin analog and a pharmaceutically suitable excipient. The dosage unit relieves constipation without substantial side effects.
Claims19
A dosage unit for use in relieving or preventing constipation in a human patient comprising a prostaglandin (PG) analog represented by Formula (I) and/or its tautomers, and a pharmaceutically suitable excipient, wherein dosage unit contains said PG analog in the range of about 6-96 μg:
- 13
- where A1 and A2 are the same or different halogen atoms and
- B is —COOH, including its pharmaceutically acceptable salts, esters or amides.
A method for relieving or preventing constipation in a human patient that comprises administering to the patient a dosage unit comprising (i) a PG analog represented by Formula (I) and/or its tautomers, in the range of about 6-96 μg and (ii) a pharmaceutically suitable excipient.
- 14
- where A1 and A2 are the same or different halogen atoms and B is —COOH, including its pharmaceutically acceptable salts, esters or amides.
Dependencies are inferred from the claim text.